This can produce a stable arrhythmia such as a ventricular tachycardia (VTach). Right: Class I drugs will selectively increase ERP in depolarized/ischemic
The 2024 ACLS guidelines for pulseless VTach recommend amio or lidocaine. Amio is easy to remember for dosing, lidocaine is weight based at 1-
vs desynchronized defibrillation in pulseless monomorphic vtach. Stable V-Tach gets drugs, unstable V-Tach gets electricity. Upvote 1
Drug of 2nd choice (vs amiodarone) to terminate VTach and prevent VFib after DC cardioversion Adenosine binds to adenosine receptors in heart tissue
High-dose epinephrine is Amiodarone or lidocaine may be consideration to Vfib/pulseless Vtach that is unresponsive to defibrillation.
Enhance your skills with VTach ACLS training. Learn to manage ventricular tachycardia in critical situations. Enroll now for expert certification!
Perform the initial assessment If the patient is in VTach or VFib, this IS a shockable rhythm Apply defibrillator pads (or paddles) and shock the patient with
Polymorphic Vtach with a prolonged QT can be treated with magnesium 1-2 mg over 15 minutes. Correct electrolyte imbalance; consider drug
Drug of 2nd choice (vs amiodarone) to terminate VTach and prevent VFib after DC cardioversion Adenosine binds to adenosine receptors in heart tissue
Comments
LWlurker